Lars Gedda
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Boron Compounds in Chemistry
- Monoclonal and Polyclonal Antibodies Research
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Radiopharmaceutical Chemistry and Applications 32
- Boron Compounds in Chemistry 17
- Monoclonal and Polyclonal Antibodies Research 4
- Biomaterials 23
- Nanoparticle-Based Drug Delivery 22
- Co-authors
- Katarina Edwards (31 shared papers)Jörgen Carlsson (23 shared papers)Karl Andersson (9 shared papers)Vladimir Tolmachev (18 shared papers)Stefan Sjöberg (15 shared papers)Erika Bohl Kullberg (9 shared papers)Hanna Björkelund (6 shared papers)Anna Orlova (12 shared papers)
- Journals
- Cancer Biotherapy and Radiopharmaceuticals (7 papers)International Journal of Oncology (5 papers)PLoS ONE (4 papers)Bioconjugate Chemistry (4 papers)Tumor Biology (4 papers)
- Partner nations
- SwedenGermanyUnited Kingdom
In The Last Decade
Lars Gedda
87 papers receiving 2k citations
Peers
Comparison fields: 5 of 83
- Radiology, Nuclear Medicine and Imaging 1k
- Biomaterials 252
- Renewable Energy, Sustainability and the Environment 177
- Drug Discovery 3
- Pharmaceutical Science 64
Countries citing papers authored by Lars Gedda
This map shows the geographic impact of Lars Gedda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Gedda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Gedda more than expected).
Fields of papers citing papers by Lars Gedda
This network shows the impact of papers produced by Lars Gedda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Gedda. The network helps show where Lars Gedda may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Gedda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 159 | |
| 2 | 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors. | 2006 | 97 |
| 3 | 2011 | 81 | |
| 4 | 2010 | 74 | |
| 5 | 2002 | 70 | |
| 6 | 2005 | 60 | |
| 7 | 2009 | 58 | |
| 8 | 2009 | 54 | |
| 9 | 1997 | 52 | |
| 10 | 2007 | 52 | |
| 11 | 2009 | 51 | |
| 12 | 1994 | 50 | |
| 13 | 2011 | 47 | |
| 14 | 2003 | 44 | |
| 15 | 2022 | 43 | |
| 16 | 2012 | 40 | |
| 17 | 2008 | 37 | |
| 18 | 2002 | 35 | |
| 19 | 2005 | 33 | |
| 20 | 2009 | 33 |
About Lars Gedda
Lars Gedda is a scholar working on Radiology, Nuclear Medicine and Imaging, Biomaterials, Oncology, Pharmaceutical Science and Molecular Biology, having authored 91 papers that have together received 2.1k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (32 papers), Nanoparticle-Based Drug Delivery (22 papers), Boron Compounds in Chemistry (17 papers), HER2/EGFR in Cancer Research (14 papers), Lipid Membrane Structure and Behavior (5 papers), Surfactants and Colloidal Systems (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1k citations), Biomaterials (252 citations), Renewable Energy, Sustainability and the Environment (177 citations), Drug Discovery (3 citations) and Pharmaceutical Science (64 citations). Lars Gedda has collaborated with scholars based in Sweden, Germany and United Kingdom. Frequent co-authors include Katarina Edwards, Jörgen Carlsson, Karl Andersson, Vladimir Tolmachev, Stefan Sjöberg, Erika Bohl Kullberg, Hanna Björkelund, Anna Orlova, Hans Lundqvist and Fredrik Y. Frejd. Their work appears in journals such as Cancer Biotherapy and Radiopharmaceuticals, International Journal of Oncology, PLoS ONE, Bioconjugate Chemistry and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.